United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

cst pharma ltd - calcipotriol monohydrate - liquid - 50microgram/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

medihealth (northern) ltd - calcipotriol monohydrate; betamethasone dipropionate - cutaneous ointment - 50microgram/1gram ; 500microgram/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

medihealth (northern) ltd - calcipotriol - cutaneous ointment - 50microgram/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

medihealth (northern) ltd - calcipotriol monohydrate - liquid - 50microgram/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

aristo pharma ltd - calcipotriol monohydrate; betamethasone dipropionate - cutaneous gel - 50microgram/1gram ; 500microgram/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - calcipotriol monohydrate; betamethasone dipropionate - cutaneous gel - 50microgram/1gram ; 500microgram/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - calcipotriol monohydrate; betamethasone dipropionate - cutaneous gel - 50microgram/1gram ; 500microgram/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - calcipotriol monohydrate; betamethasone dipropionate - cutaneous gel - 50microgram/1gram ; 500microgram/1gram

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - betamethasone dipropionate 0.643 mg/g equivalent to betamethasone base 0.500 mg/g; calcipotriol 0.05 mg/g;   - topical ointment - active: betamethasone dipropionate 0.643 mg/g equivalent to betamethasone base 0.500 mg/g calcipotriol 0.05 mg/g   excipient: butylated hydroxytoluene liquid paraffin polyoxypropylene monostearyl ether white soft paraffin - calcipotriol /betamethasone (teva) is indicated for the once daily topical treatment of plaque-type psoriasis vulgaris amenable to topical therapy in adult patients 18 years and older.

New Zealand - English - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - betamethasone dipropionate 0.643 mg/g equivalent to betamethasone 0.50mg; calcipotriol monohydrate 0.0522 mg/g equivalent to calcipotriol 0.050mg - topical ointment - active: betamethasone dipropionate 0.643 mg/g equivalent to betamethasone 0.50mg calcipotriol monohydrate 0.0522 mg/g equivalent to calcipotriol 0.050mg excipient: d-alpha tocoferol liquid paraffin oleyl alcohol white soft paraffin - calcipotriol and betamethasone ointment is indicated for the once daily topical treatment of plaque-type psoriasis vulgaris amenable to topical therapy in patients 18 years and older.